Par GlaxoSmithKline Latvia, SIA (Reģ.Nr.40003633032, Bruņinieku iela 5, Rīga, LV–1001) medikamenta Celsentri apvalkotas tabletes 300mg Nr.60 pacientu skaitu zāļu iegādes kompensācijas sistēmā
In force· 2 articles· Issued by: Veselības ekonomikas centrs· In force from: Tue Jan 18
Verify on the source (likumi.lv) ↗Reference only — not legal advice. The corpus mirrors statutory text (including repealed editions); a result may be superseded. Always verify against the current consolidated version on likumi.lv before relying on it.